Search

Your search keyword '"Central nervous system depressants -- Research"' showing total 4 results
Start Over Descriptor "Central nervous system depressants -- Research" Publisher plus media
4 results on '"Central nervous system depressants -- Research"'

1. Intellipharmaceutics Announces Completion of the Clinical Component of Category 2 and 3 Human Abuse Liability Studies for Oxycodone ER

Subjects
United States. Food and Drug Administration, Legal liability, Oxycodone -- Research, Central nervous system depressants -- Research, General interest, News, opinion and commentary
Abstract

TORONTO: Intellipharmaceutics International Inc. has issued the following news release: Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX : IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in the research, development [...]

Published
2018

2. Sension Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance

Subjects
Meclizine -- Research, Central nervous system depressants -- Research, Medical research, General interest, News, opinion and commentary
Abstract

Amsterdam: SENSORION has issued the following news release: Sensorion (Paris: ALSEN) (FR0012596468 - ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announced the initiation of [...]

Published
2018

3. Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER Updated on 08-05-2018

Subjects
United States. Food and Drug Administration, Legal liability, Oxycodone -- Research, Central nervous system depressants -- Research, General interest, News, opinion and commentary
Abstract

Toronto: Intellipharmaceutics International Inc has issued the following news release: Intellipharmaceutics International Inc. (NASDAQ and TSX: IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in the research, development and [...]

Published
2018

4. Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER

Subjects
United States. Food and Drug Administration, Legal liability, Oxycodone -- Research, Central nervous system depressants -- Research, General interest, News, opinion and commentary
Abstract

TORONTO: Intellipharmaceutics International Inc. has issued the following news release: Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX: IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in the research, development and [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results